Extrawell Pharmaceutical Holdings Ltd Sustainability Reports
Extrawell Pharmaceutical Holdings Limited focuses on the development, manufacture, marketing, and distribution of pharmaceutical products, as well as oral insulin commercialization projects. Its operations primarily span across Hong Kong and mainland China.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
FIGI: BBG001S8TZ73
17 reports from 2007 to 2025
